Cdc25 is a dual specificity phosphatase with three isoforms in mammalian cells - Cdc25A, B and C. Cdc25 activates cdk complexes that control progression through the cell cycle. Cdc25 is also involved in the DNA damage checkpoints.
Regulation of Cdc25 occurs through a variety of mechanisms including phosphorylation, interaction with 14.3.3 proteins, subcellular localization and protein degradation. Cdc25B is phosphorylated and activated by aurora kinase A at the start of mitosis, and as mitosis progresses is then further phosphorylated in an auto-amplification loop, along with Cdc25C, by the CDK1/cyclin B complex. Cdc25C is also phosphorylated during mitosis by PLK1, leading to greater activity of the CDK1/cyclin B complex. Similarly, Cdc25A acts during the G1/S phase of the cell cycle in concert with the CDK2/cyclin E complex. Both Cdc25A and Cdc25B can be activated by the DNA damage checkpoint kinase, Chk1 and thereby inhibit mitosis.
Cdc25 is a key mediator of cell cycle progression. Consequently, there is a strong link between Cdc25 and cancer. Expression of Cdc25A and Cdc25B is upregulated in certain cancer types, frequently those with more aggressive tumors and poor prognosis; the development of specific Cdc25 inhibitors is therefore of great therapeutic interest.View all products for Cdc25 Phosphatase »
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
|View all Cdc25 Phosphatase Gene Data »|
Literature for Cdc25 Phosphatase
A collection of over 750 products for cancer research, the guide includes research tools for the study of:
- Cancer Metabolism
- Epigenetics in Cancer
- Receptor Signaling
- Cell Cycle and DNA Damage Repair
- Invasion and Metastasis
Find multiple products by catalog number
October 30 - November 3, 2016
Boston, MA, USA